First Botox generic to be marketed by Meditox.

Published: 2006-03-21 07:00:00
Updated: 2006-03-21 07:00:00
Meditox, a Korean bio venture company, has obtained the KFDA approval for the sale of "botulism injection", a generic of Botox, through their own technical development.

The development of an injectable botulism by Meditox would be the 4th in the world, first in Korea, the company said.

The...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.